1-4 of 4
M. Gardembas
Close
Sort by
Journal Articles

Patient Characteristics, Quality-of-Life and Compliance with Deferoxamine in Patients with Transfusional Iron Overload: Results of ‘ISOSFER’ Study.

I. Thuret, C. Brun-Strang, D. Bachir, M. Hacini, B. Pegourie-Bandelier, M. Gardembas-Pain
Journal: Blood
Blood (2006) 108 (11): 5513.
https://doi.org/10.1182/blood.V108.11.5513.5513
Published: 2006
Journal Articles

Low Doses of Thalidomide (Thal) in Low Risk MDS with Transfusion-Dependant Anemia: The GFM THAL-SMD-200 Trial.

J. Tamburini, C. Elie, D. Vassilief, M.C. Quarre, O. Beyne-Rauzy, M. Gardembas, A. Aouba, C. Berthou, L. Sanhes, A. Guerci, A. Stamatoullas, F. Bauduer, J.J. Sotto, L. Legros, S. Vaultier, P. Fenaux, F. Dreyfus, D. Bouscary
Journal: Blood
Blood (2006) 108 (11): 2673.
https://doi.org/10.1182/blood.V108.11.2673.2673
Published: 2006
Journal Articles

Is There a Role for ATRA in Combination to EPO in Lower Risk Myelodysplastic Syndrome? Preliminary Results of a Phase II Study.

L. Ades, H. Mohamed, D. Vassilief, E. Berger, B. Slama, N. Vey, R. Delarue, O. Beyne-Rauzy, A. Guerci, S. Cheze, X. Thomas, A. Stamatoullas, M. Gardembas, F. Bauduer, A. Kolb, M.C. Chaury, L. Legros, G. Damaj, F. Hamza, S. Vaultier, F. Dreyfus, P. Fenaux
Journal: Blood
Blood (2005) 106 (11): 2537.
https://doi.org/10.1182/blood.V106.11.2537.2537
Published: 2005
Journal Articles

Incidence, Clinical Features, and Outcome of All Trans -Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia

S. De Botton, H. Dombret, M. Sanz, J. San Miguel, D. Caillot, R. Zittoun, M. Gardembas, A. Stamatoulas, E. Condé, A. Guerci, C. Gardin, K. Geiser, D. Cony Makhoul, O. Reman, J. de la Serna, F. Lefrere, C. Chomienne, C. Chastang, L. Degos, P. Fenaux, the European APL Group
Journal: Blood
Blood (1998) 92 (8): 2712–2718.
https://doi.org/10.1182/blood.V92.8.2712
Published: 1998